These estimates align with the Brazilian Society of Surgical Oncology and the National Comprehensive Cancer Network recommendations, which suggest genetic counseling and evaluation of BRCA1 and BRCA2 for all women diagnosed with epithelial ovarian cancer (including fallopian tube and peritoneal cancer), regardless of age [6, 7]. This evidence concerns the gene BRCA2 and ovarian carcinoma.